Literature DB >> 16828551

Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonist.

Stephan Schann1, Christel Menet, Paul Arvault, Géraldine Mercier, Mélanie Frauli, Stanislas Mayer, Nadia Hubert, Nicolas Triballeau, Hugues-Olivier Bertrand, Francine Acher, Pascal Neuville.   

Abstract

A new family of mGlu receptor orthosteric ligands called APTCs was designed and synthesized using a parallel chemistry approach. Amongst 65 molecules tested on mGlu4, mGlu6 and mGlu8 subtypes, (2S,4S)-4-amino-1-[(E)-3-carboxyacryloyl]pyrrolidine-2,4-dicarboxylic acid (8a06-FP0429) has been shown to be a full mGlu4 agonist and a partial mGlu8 agonist. In addition, 8a06 was shown to be selective versus group I and II mGlu subtypes. A possible explanation for this efficacy difference is proposed by docking experiment performed with molecular model of the receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828551     DOI: 10.1016/j.bmcl.2006.06.062

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Recent Progress on the Stereoselective Synthesis of Cyclic Quaternary alpha-Amino Acids.

Authors:  Carlos Cativiela; Mario Ordóñez
Journal:  Tetrahedron Asymmetry       Date:  2009-01-30

2.  Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease.

Authors:  Sebastien Lopez; Nathalie Turle-Lorenzo; Francine Acher; Elvira De Leonibus; Andrea Mele; Marianne Amalric
Journal:  J Neurosci       Date:  2007-06-20       Impact factor: 6.167

3.  Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.

Authors:  Helena Domin; Krystyna Gołembiowska; Danuta Jantas; Katarzyna Kamińska; Barbara Zięba; Maria Smiałowska
Journal:  Neurotox Res       Date:  2014-01-09       Impact factor: 3.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.